Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0000950170-25-073746

Director acquired 5,144 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GANNON STEVEN · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-05-14 Exercise or conversion : show line 1 in the form +5,144 $12.57 $64,660 7,144 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-05-14 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −5,144 0 D
Loading xslF345X05/ownership.xml…